DealsTemasek leads €255m investment round in ITMITM is a radiopharmaceutical biotech company headquartered in Munich, Germany.ByIrien Joseph7 June 2023•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsEuropeUKWestern EuropeHealthcareTMT